FVC는 마이코페놀산염의 결합 사용에 의해 억제되었지만, 닌테다닙의 억제는 부가적인 효과였으며, 또한 결합된 사용도 안전을 보장했다.
FVC was suppressed by the combined use of mycophenolate, but the suppression of nintedanib was an additive effect, and the combined use also ensured the safety.